Yuksel E, Weinfeld A B, Cleek R, Wamsley S, Jensen J, Boutros S, Waugh J M, Shenaq S M, Spira M
Division of Plastic Surgery at Baylor College of Medicine, Houston, Texas, USA.
Plast Reconstr Surg. 2000 Apr;105(5):1712-20. doi: 10.1097/00006534-200004050-00017.
The present investigation evaluates the effects of long-term, local delivery of insulin, insulin-like growth factor-1 (IGF-1), and basic fibroblast growth factor (bFGF) on fat-graft survival using a poly (lactic-co-glycolic-acid)-polyethylene glycol (PLGA/PEG) microsphere delivery system. Twelve-micrometer PLGA/PEG microspheres incorporated separately with insulin, IGF-1, and bFGF were manufactured using a double-emulsion solvent-extraction technique. Inguinal fat from Sprague Dawley rats was harvested, diced, washed, and mixed with (1) insulin microspheres, (2) insulin-like growth factor-1 microspheres, (3) basic fibroblast growth factor microspheres, (4) a combination of the insulin and IGF-1 microspheres, and (5) a combination of insulin, IGF-1, and bFGF microspheres. The treated fat grafts were implanted autologously into subdermal pockets in six animals for each group. Animals receiving untreated fat grafts and fat grafts treated with blank microspheres constituted two external control groups (six animals per external control group). At 12 weeks, all fat-graft groups were compared on the basis of weight maintenance and a histomorphometric analysis of adipocyte area percentage, indices of volume retention and cell composition, respectively. Weight maintenance was defined as the final graft weight as a percent of the implanted graft weight. All growth factor treatments significantly increased fat-graft weight maintenance objectively, and volume maintenance grossly, in comparison with the untreated and blank microsphere-treated controls. Treatment with insulin and IGF-1, alone or in combination, was found to increase the adipocyte area percentage in comparison with fat grafts treated with bFGF alone or in combination with other growth factors. In conclusion, the findings of this study indicate that long-term, local delivery of growth factors with PLGA/PEG microspheres has the potential to increase fat-graft survival rates. Further, the type of growth factor delivered may influence the cellular/stromal composition of the grafted tissue.
本研究使用聚(乳酸-乙醇酸)-聚乙二醇(PLGA/PEG)微球递送系统,评估长期局部递送胰岛素、胰岛素样生长因子-1(IGF-1)和碱性成纤维细胞生长因子(bFGF)对脂肪移植存活的影响。采用双乳液溶剂萃取技术制备分别与胰岛素、IGF-1和bFGF结合的12微米PLGA/PEG微球。从Sprague Dawley大鼠腹股沟处采集脂肪,切成小块,冲洗后与以下物质混合:(1)胰岛素微球;(2)胰岛素样生长因子-1微球;(3)碱性成纤维细胞生长因子微球;(4)胰岛素和IGF-1微球的组合;(5)胰岛素、IGF-1和bFGF微球的组合。将处理后的脂肪移植物自体植入每组6只动物的皮下囊袋中。接受未处理脂肪移植物和用空白微球处理的脂肪移植物的动物构成两个外部对照组(每个外部对照组6只动物)。在12周时,分别根据重量维持情况以及脂肪细胞面积百分比、体积保留指数和细胞组成的组织形态计量学分析,对所有脂肪移植组进行比较。重量维持定义为最终移植物重量占植入移植物重量的百分比。与未处理和用空白微球处理的对照组相比,所有生长因子处理均显著客观地增加了脂肪移植的重量维持,总体上也增加了体积维持。与单独用bFGF或与其他生长因子联合处理的脂肪移植相比,发现单独或联合使用胰岛素和IGF-1处理可增加脂肪细胞面积百分比。总之,本研究结果表明,用PLGA/PEG微球长期局部递送生长因子有可能提高脂肪移植存活率。此外,所递送的生长因子类型可能会影响移植组织的细胞/基质组成。